Synmosa Biopharma Corporation (TPEX:4114)
Taiwan · Delayed Price · Currency is TWD 31.75
-0.20 (-0.63%)
Apr 20, 2026, 1:00 PM CST
Synmosa Biopharma Market Cap
Synmosa Biopharma has a market cap or net worth of 16.06 billion as of April 17, 2026. Its market cap has increased by 12.76% in one year.
Market Cap
16.06B
Enterprise Value
16.98B
Revenue
6.19B
Ranking
n/a
PE Ratio
19.25
Stock Price
31.75
Market Cap Chart
Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 16.06B, an increase of 2,653.10%. That is a compound annual growth rate of 18.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 16.06B | -1.13% |
| Dec 31, 2025 | 16.25B | 12.06% |
| Dec 31, 2024 | 14.50B | -1.41% |
| Dec 29, 2023 | 14.71B | -8.20% |
| Dec 30, 2022 | 16.02B | 128.36% |
| Dec 30, 2021 | 7.02B | 2.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 30.16B |
| TTY Biopharm Company | 18.55B |
| Grape King Bio | 17.55B |
| ScinoPharm Taiwan | 17.32B |
| YungShin Global Holding | 14.76B |
| Handa Pharmaceuticals | 13.36B |
| Foresee Pharmaceuticals | 12.07B |
| Standard Chemical & Pharmaceutical | 11.26B |